Company: ERAS
Filing Date: 2025-05-15
Form Type: SCHEDULE 13G/A
Source: 0001415889-25-012990
Chunk: 1

Company: Erasca, Inc.
Filing Date: 2025-05-15
Form: SCHEDULE 13G/A
Chunk 1
---
.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences Public Overage Fund, L.P. The percentage listed in row 11 is calculated based on 283,265,716 shares of Common Stock outstanding on March 13, 2025, as set forth in the Issuer's Annual Report on Form 10-K filed with the SEC on March 20, 2025.

| SCHEDULE 13G |

| CUSIP No. | 29479A108 |

| 1                                                                  |                                                                  FHMLSP Overage, L.L.C. |
| 2                                                                  |                                                                                   -a)(b |
| 3                                                                  |                                                                            Sec Use Only |
| 4                                                                  |                                                                                DELAWARE |
| Number of Shares Beneficially Owned by Each Reporting Person With: |                                                                       5          0.00   
                                                                       6  2,373,243.00   
                                                                       7          0.00   
                                                                         8  2,373,243.00 |
| 9                                                                  |                                                                            2,373,243.00 |
| 10                                                                 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions) |
| 11                                                                 |                                                                                   0.8 % |
| 12                                                                 |                                                                                      OO |

Comment for Type of Reporting Person:The shares listed in rows 6, 8 and 9 consist of 2,373,243 shares of Common Stock held directly by Frazier Life Sciences Public Overage Fund, L.P. FHMLSP Overage, L.P. is the general partner of Frazier Life Sciences Public Overage Fund, L.P. and FHMLSP Overage, L.L.C. is the general partner of FHMLSP Overage, L.P. Patrick J. Heron, James N. Topper, Albert Cha and James Brush are the members of FHMLSP Overage, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences Public Overage Fund, L.P. The percentage listed in row 11 is calculated based on 283,265,716 shares of Common Stock outstanding on March 13, 2025, as set forth in the Issuer's Annual Report on Form 10-K filed with the SEC on March 20, 2025.

| SCHEDULE 13G |

| CUSIP No. | 29479A108 |

| 1                                                                  |